Compound

D0846 | chrysarobin

Molecular Formula C15H12O3
Molecular Weight 240.25
Structure

Toxicity Dose Time Species Model Method Action Positive criterion Reference
MEMBRANE POTENTIAL 22.82±3.93 human qHTS-HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 30.83 human HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 19.29±8.27 rat hepatocytes MMP assay decrease IC50 163


  • 0433FJV3CI 1,8,9-Anthracenetriol, 3-methyl- 1,8,9-Trihydroxy-3-methylanthracene
    1,8-Dihydroxy-3-methylanthron 2C15H12O3 3-Methyl-1,8,9-anthracenetriol
    3-Methyl-1,8,9-trihydroxyanthracene 3-Methyl-1,8-dihydroxy-9,10-dihydro-9-oxoanthracen 3-Methylanthralin
    3-methylanthracene-1,8,9-triol 4-06-00-07604 (Beilstein Handbook Reference) 491-59-8
    9-hydroxy chrysarobin ACM491598 AI3-62089
    BRN 2124735 CAS-491-59-8 CCRIS 5597
    CHEMBL2135835 CTK4J1116 Chrysophanic acid anthranol
    Chrysophansaureanthranol DB-051605 DSSTox_CID_28597
    DSSTox_GSID_48671 DSSTox_RID_82868 DTXSID1048671
    FT-0632219 JBGKVNQFVAJOGC-UHFFFAOYSA-N LS-187737
    LS-20394 NCGC00181774-01 NCGC00181774-02
    Purified araroba Purified goa powder Q27247612
    SCHEMBL5858623 Tox21_113041 Tox21_113041_1
    UNII-0433FJV3CI ZINC100090070

    CAS Number 491-58-7, 491-59-8, 51510-26-0
    PubChem Compound 10288
    KEGG Compound ID C10314
    ChEBI 3686
    ChemSpider 9867